hydralazine has been researched along with Chagas Cardiomyopathy in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Chagas Cardiomyopathy: A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marin-Neto, JA | 1 |
| Secches, AL | 1 |
| Maciel, BC | 1 |
| Gallo Júnior, L | 1 |
| Terra-Filho, J | 1 |
| Manço, JC | 1 |
| Amorin, DS | 1 |
1 other study available for hydralazine and Chagas Cardiomyopathy
| Article | Year |
|---|---|
[Chronic Chagas' cardiopathy-- use of vasodilators in uncompensated heart failure].
Topics: Adolescent; Adult; Chagas Cardiomyopathy; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans | 1982 |